Reappraisal of the Risks and Benefits of Major Liver Resection in Patients With Initially Unresectable Colorectal Liver Metastases

Risk Factors for Liver Failure and Mortality After Hepatectomy Associated With Portal Vein Resection

(2011) Philippe Bachellier et al.   ANNALS OF SURGERY

Patients Operated On for Initially Unresectable Colorectal Liver Metastases With Missing Metastases Experience a Favorable Long-Term Outcome

(2011) Diane Goèré et al.   ANNALS OF SURGERY

Impact of Expanding Criteria for Resectability of Colorectal Metastases on Short- and Long-Term Outcomes After Hepatic Resection

(2011) Robbert J. de Haas et al.   ANNALS OF SURGERY

Two-stage hepatectomy for multiple bilobar colorectal liver metastases

(2011) M. Narita et al.   BRITISH JOURNAL OF SURGERY

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

(2011) Antoine Brouquet et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting High Grade Lesions of Sinusoidal Obstruction Syndrome Related to Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases

(2010) Olivier Soubrane et al.   ANNALS OF SURGERY

Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases

(2010) Diane Goéré et al.   ANNALS OF SURGERY

Regenerative Nodular Hyperplasia of the Liver Related to Chemotherapy: Impact on Outcome of Liver Surgery for Colorectal Metastases

(2010) Dennis A. Wicherts et al.   ANNALS OF SURGICAL ONCOLOGY

Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

(2010) Yoji Kishi et al.   ANNALS OF SURGICAL ONCOLOGY

Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy

(2009) Hiroshi Nakano et al.   ANNALS OF SURGERY

Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Hiromichi Ito et al.   ANNALS OF SURGERY

Preoperative Liver Hypertrophy Induced by Portal Flow Occlusion Before Major Hepatic Resection for Colorectal Metastases Can Be Impaired by Bevacizumab

(2009) Béatrice Aussilhou et al.   ANNALS OF SURGICAL ONCOLOGY

Resection Margin and Recurrence-Free Survival After Liver Resection of Colorectal Metastases

(2009) Andrea Muratore et al.   ANNALS OF SURGICAL ONCOLOGY

Risk Factors and Management of Ascites After Liver Resection to Treat Hepatocellular Carcinoma

(2009) Takeaki Ishizawa   ARCHIVES OF SURGERY

Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases

(2009) M. Klinger et al.   EJSO

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

(2009) Gunnar Folprecht et al.   LANCET ONCOLOGY

Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases

(2009) Antoine Brouquet et al.   SURGERY

Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases

(2008) Dennis A. Wicherts et al.   ANNALS OF SURGERY

Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases

(2008) Daria Zorzi et al.   ANNALS OF SURGICAL ONCOLOGY